According to a new CDC report, only one-third of individuals with documented hepatitis C diagnosis were cured over the past decade. Based on data which spanned from 2013 to 2022, the report also found that for patients without health insurance under the age of 40 years, only 1 in 6 have been cured.

New research published in JAMA shows that once-weekly insulin icodec is safe for people with T2D. It also showed that individuals with T2D who used insulin icodec maintained healthier blood glucose levels compared with people who received daily injections of insulin degludec.

Community pharmacies in the United States “played a vital role in the public health response to the COVID-19 pandemic,” said a new commentary published June 29, 2023, in JAMA Forum.

Nearly one-half of Americans said they would be willing to spend up to $100 a month for new weight loss medicines such as semaglutide (Wegovy—Novo Nordisk), and one-third said they would indefinitely pay whatever they can afford to get the drugs, according to a new survey by STAT and Harris Poll.

The prevalence of diabetes is expected to more than double by 2050, according to a new Lancetstudy. Approximately 1 in 10 people worldwide at that time will have diabetes, marking a 60% increase in the prevalence of the disease, said the study findings.